TCL Archive Children, Parents Differ In Decisionmaking On Cancer Treatment, Survivor Study Finds July 29, 2005
TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online February 5, 1999
TCL Archive Cancer Society, With Level Budget, Cuts On More Money to Fund “Pay Ifs” In FY92 March 27, 1992
